Optibrium Ltd is a specialized software development company focused on providing data-driven insights and alerts to the pharmaceutical and biotechnology industries. Founded in 2008, the company operates as a limited liability company (Ltd) with a registered address at F10-13 Blenheim House, Cambridge Innovation Park, Cambridge, CB25 9GL. Optibrium’s core business involves the development and maintenance of sophisticated monitoring and analysis tools. These tools are designed to identify potential risks and opportunities within complex biological data sets, particularly related to drug development and clinical trials. The company’s primary service offerings include real-time monitoring of key biomarkers, adverse events, and clinical trial data. Optibrium leverages a unique combination of data science, statistical modeling, and specialized software to generate alerts and recommendations for pharmaceutical companies, research institutions, and regulatory bodies. They offer a range of analytical services, including data visualization, trend analysis, and predictive modeling. Optibrium’s activities are primarily concentrated within the biotechnology and pharmaceutical sectors, with a significant international presence, though the company currently maintains limited operational presence outside of the UK. The company is structured as a Skilled Worker visa holder, currently rated as a Worker (A rating) with a focus on continuous innovation and data-driven decision-making.

Optibrium Ltd is a specialized software development company focused on providing data-driven insights and alerts to the pharmaceutical and biotechnology industries. Founded in 2008, the company operates as a limited liability company (Ltd) with a registered address at F10-13 Blenheim House, Cambridge Innovation Park, Cambridge, CB25 9GL. Optibrium’s core business involves the development and maintenance of sophisticated monitoring and analysis tools. These tools are designed to identify potential risks and opportunities within complex biological data sets, particularly related to drug development and clinical trials. The company’s primary service offerings include real-time monitoring of key biomarkers, adverse events, and clinical trial data. Optibrium leverages a unique combination of data science, statistical modeling, and specialized software to generate alerts and recommendations for pharmaceutical companies, research institutions, and regulatory bodies. They offer a range of analytical services, including data visualization, trend analysis, and predictive modeling. Optibrium’s activities are primarily concentrated within the biotechnology and pharmaceutical sectors, with a significant international presence, though the company currently maintains limited operational presence outside of the UK. The company is structured as a Skilled Worker visa holder, currently rated as a Worker (A rating) with a focus on continuous innovation and data-driven decision-making.